Advertisement
Advertisement
Trending on Dermatology Times
1
Probiotics in Hidradenitis Suppurativa: Biologic Rationale vs. Clinical Evidence
2
Envudeucitinib Achieves 54% PASI 100 Rate at 48 Weeks in Phase 3 Extension
3
GPP Awareness Day: Flare Triggers and IL-36 Targeted Therapy With Spesolimab
4
Addressing Treatment Hesitancy in Pediatric Psoriasis
5